Humana Inc. (NYSE:HUM) Shares Sold by Ferguson Wellman Capital Management Inc.

Ferguson Wellman Capital Management Inc. lowered its position in shares of Humana Inc. (NYSE:HUM) by 0.4% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 10,945 shares of the insurance provider’s stock after selling 40 shares during the quarter. Ferguson Wellman Capital Management Inc.’s holdings in Humana were worth $3,467,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Mendota Financial Group LLC lifted its stake in Humana by 9.2% during the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after purchasing an additional 27 shares during the last quarter. Capital Advisors Ltd. LLC boosted its holdings in shares of Humana by 17.0% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock valued at $80,000 after buying an additional 31 shares in the last quarter. CarsonAllaria Wealth Management Ltd. grew its position in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after buying an additional 39 shares during the last quarter. Harbour Investments Inc. raised its stake in Humana by 10.5% during the 2nd quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock worth $161,000 after acquiring an additional 41 shares in the last quarter. Finally, Baader Bank Aktiengesellschaft lifted its position in Humana by 1.0% in the second quarter. Baader Bank Aktiengesellschaft now owns 4,421 shares of the insurance provider’s stock valued at $1,649,000 after acquiring an additional 42 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently commented on HUM shares. Deutsche Bank Aktiengesellschaft cut their target price on Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Oppenheimer cut their price target on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. Leerink Partnrs downgraded Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Barclays cut their target price on shares of Humana from $364.00 to $250.00 and set an “equal weight” rating on the stock in a report on Thursday, October 10th. Finally, UBS Group decreased their price target on shares of Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, October 4th. One analyst has rated the stock with a sell rating, nineteen have issued a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $315.33.

Humana Price Performance

HUM stock traded up $0.80 on Friday, reaching $267.14. 4,660,847 shares of the company’s stock were exchanged, compared to its average volume of 1,846,211. The stock has a fifty day moving average of $315.89 and a 200-day moving average of $338.27. The firm has a market cap of $32.19 billion, a PE ratio of 16.64, a P/E/G ratio of 1.91 and a beta of 0.50. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $527.18.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business’s revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the firm earned $8.94 EPS. As a group, equities analysts predict that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio is currently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.